Clinical Trials
3 trialsNCT07533942 2026-04-16
A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
Jazz Pharmaceuticals
Phase 2 Not yet recruiting
NCT07282587 2026-02-27
Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
Jazz Pharmaceuticals
Phase 2 Recruiting
NCT04541082 2025-12-18
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Jazz Pharmaceuticals
Phase 1 Recruiting